Mepolizumab in the treatment of severe eosinophilic asthma.
about
What we know about nonsteroidal anti-inflammatory drug hypersensitivityObesity alters the lung myeloid cell landscape to enhance breast cancer metastasis through IL5 and GM-CSF.Benralizumab for the treatment of asthma.dNP2-ctCTLA-4 inhibits German cockroach extract-induced allergic airway inflammation and hyper-responsiveness via inhibition of Th2 responses.Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab.
P2860
Mepolizumab in the treatment of severe eosinophilic asthma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Mepolizumab in the treatment of severe eosinophilic asthma.
@en
type
label
Mepolizumab in the treatment of severe eosinophilic asthma.
@en
prefLabel
Mepolizumab in the treatment of severe eosinophilic asthma.
@en
P2860
P356
P1433
P1476
Mepolizumab in the treatment of severe eosinophilic asthma.
@en
P2093
Giovanna Pisi
P2860
P356
10.2217/IMT.15.102
P577
2015-12-10T00:00:00Z